In November, Mounjaro clocked Rs 108 crore in sales, making it the number 1 brand in the IPM, reflecting sustained momentum ...
Structure Therapeutics said on Monday that its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study.
3hon MSN
GLP-1 drugs have ‘little or no effect’ on risk of obesity-related cancers, study suggests
Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback